Scientific breakthrough reveals how vitamin B12 is made

August 8, 2013

(Phys.org) —A scientific breakthrough by researchers at the University of Kent has revealed how vitamin B12/antipernicious anaemia factor is made – a challenge often referred to as 'the Mount Everest of biosynthetic problems'.

Vitamin B12 is pieced together as an elaborate molecular jigsaw involving around 30 individual components. It is unique amongst the vitamins in that it is only made by certain bacteria. In the early 1990's it was realised that there were two pathways to allow its construction – one that requires oxygen and one that occurs in the absence of oxygen. It is this so-called anaerobic pathway, which is the more common pathway, that proved so elusive as the components of the pathway are very unstable and rapidly degrade.

However, as explained in a paper published by PNAS (Proceedings of the National Academy of Sciences), bioscientists at the University of Kent have trained a friendly called Bacillus megaterium to produce all of the components of the anaerobic B12 . This has helped them acquire the missing molecular pieces of the jigsaw, allowing them to complete the picture of how this remarkable molecule is made.

The team hopes that this newly acquired information can be used to help persuade bacteria to make the vitamin in larger quantities, thereby contributing to its use in medication for people suffering with the pernicious anaemia, amongst other things.

Professor Martin Warren, who led the research, said: 'This is a really exciting time in the – one where our knowledge can be applied with the emerging discipline of synthetic biology to produce strains of bacteria that make enough B12, and other vitamins, for use in medicine and other sectors, such as feed for livestock.'

Key academic partners in the research included Dr Rebekka Biedendieck (Braunschweig University of Technology) and Dr Steve Rigby (Manchester Institute of Biotechnology). The Kent team also included Dr Simon Moore and Dr Mark Howard, Reader in Biological NMR Spectroscopy.

The research was funded by a grant from the Biotechnology and Biological Sciences Research Council (BBSRC) to Professor Warren and Dr Howard.

Explore further: Vitamins doing gymnastics: Scientists capture first full image of vitamin B12 in action

More information: 'Elucidation of the anaerobic pathway for the corrin component of cobalamin (vitamin B12)' can be viewed online at www.pnas.org/content/early/2013/08/06/1308098110

Related Stories

Recommended for you

Antibody-making bacteria promise drug development

August 31, 2015

Monoclonal antibodies, proteins that bind to and destroy foreign invaders in our bodies, routinely are used as therapeutic agents to fight a wide range of maladies including breast cancer, leukemia, asthma, arthritis, psoriasis, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.